2025
SJR Q3
JCR Q4 · 1,1
OA
14 matched articles
ESCI
Journal detail
Medical Mycology Case Reports
- Publisher
- Elsevier B.V.
- Country
- Netherlands · Western Europe
- Type
- journal
- ISSN
-
22117539
Integrated evaluation
Scopus side is Scimago SJR; WoS side is Master Journal List + JCR/JIF. Sources are matched on ISSN. WoS / JCR metrics are available for 1997 and later years only.
WoS / JCR data covers 1997 onward.
Scopus
Scopus · Scimago
- SJR 0,377
- Quartile Q3
- H-Index 27
- Cites/doc 1,32
- Docs (3y) 173
- Cites (3y) 245
Clarivate
Web of Science · JCR · 2025
- JCR Q Q4
- JIF 1,1
- 5Y JIF 1,2
- JCI 0,29
WoS indexes
- ESCI
Subject classification
Categories (SJR)
- Infectious Diseases Q3
- Microbiology Q4
Areas
- Immunology and Microbiology
- Medicine
WoS categories
- Medicine, Research & Experimental
Yearly quartile comparison
Scimago (SJR) for all years; Clarivate (JCR / JIF / JCI) from 1997 onward. Latest year stays open; older years start collapsed.
WoS / JCR data covers 1997 onward.
| Year | SJR Q | JCR Q (1997+) | SJR | JIF (1997+) | 5Y JIF (1997+) | JCI (1997+) | JCI Q (1997+) | H-Index |
|---|---|---|---|---|---|---|---|---|
| 2025 | Q3 | Q4 | 0,377 | 1,1 | 1,2 | 0,29 | Q4 | 27 |
| 2024 | Q3 | Q4 | 0,37 | 1,3 | 1,3 | 0,47 | Q3 | 25 |
| 2023 | Q3 | Q3 | 0,327 | 1,6 | 1,3 | 0,54 | Q3 | 25 |
| 2022 | Q3 | — | 0,364 | 2,2 | 1,6 | 0,59 | Q3 | 25 |
| 2021 | Q3 | — | 0,324 | — | — | 0,32 | Q4 | 25 |
| 2020 | Q3 | — | 0,422 | — | — | 0,37 | Q4 | 25 |
| 2019 | Q3 | — | 0,404 | — | — | — | — | 25 |
| 2017 | Q3 | — | 0,258 | — | — | — | — | 25 |
| 2016 | Q3 | — | 0,431 | — | — | — | — | 25 |
| 2015 | Q3 | — | 0,391 | — | — | — | — | 25 |
| 2014 | Q3 | — | 0,282 | — | — | — | — | 25 |
| 2013 | Q4 | — | 0,117 | — | — | — | — | 25 |
| 2012 | — | — | — | — | — | — | — | 25 |
JCR category quartile history
JCR / JCI quartile by year and category. 1997 and later.
WoS / JCR data covers 1997 onward.
| Year | Category | Edition | JCR Q (1997+) | JCI Q (1997+) | Rank |
|---|---|---|---|---|---|
| 2025 | MEDICINE, RESEARCH & EXPERIMENTAL | ESCI | Q4 | Q4 | 153/191 |
| 2024 | MEDICINE, RESEARCH & EXPERIMENTAL | ESCI | Q4 | Q3 | 153/195 |
| 2023 | MEDICINE, RESEARCH & EXPERIMENTAL | ESCI | Q3 | Q3 | 137/189 |
| 2022 | MEDICINE, RESEARCH & EXPERIMENTAL | ESCI | — | Q3 | — |
| 2021 | MEDICINE, RESEARCH & EXPERIMENTAL | ESCI | — | Q4 | — |
| 2020 | MEDICINE, RESEARCH & EXPERIMENTAL | ESCI | — | Q4 | — |